A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers

Clinical trial NCT04901078 · COMPLETED

Trial details

NCT number: NCT04901078
Sponsor: Kinoxis Therapeutics Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Study Opioid-use Disorder

Start date: 2022-04-07
Primary completion: 2023-09-30
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.